Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new 'revolutionary' therapeutics?

Autor: Harvima IT; Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland., Harvima RJ; Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Jazyk: angličtina
Zdroj: The British journal of dermatology [Br J Dermatol] 2022 Jul; Vol. 187 (1), pp. 6-7. Date of Electronic Publication: 2022 Apr 12.
DOI: 10.1111/bjd.21583
Databáze: MEDLINE